Company news
Diaceutics Plc (LSE:DXRX) news
Diaceutics Plc news releases on 6ix. Latest, Oct 6, 2026: PDMR Shareholding/SIP and Total Voting Rights
Press releases & updates
PDMR Shareholding/SIP and Total Voting Rights
October 6, 2026
Diaceutics and Syndax expand Relay partnership
September 24, 2026
Interim Results - six months ended 30 June 2026
September 22, 2026
Diaceutics and PCC launch NGS Concordance Study
August 20, 2026
75% ARR Growth Drives Revenue & Profit Visibility
July 29, 2026
PDMR Shareholding/Share Incentive Plan & TVRs
June 1, 2026
Notice of AGM & Posting of Annual Report
May 29, 2026
Related Party Transaction - Lease Extension
April 16, 2026
Block Listing Return
April 7, 2026
PDMR Shareholding/SIP & Total Voting Rights
April 1, 2026
PDMR Shareholding/Share Incentive Plan and TVRs
March 3, 2026
PDMR Shareholding/Share Incentive Plan & TVR
February 3, 2026
Full Year 2025 Trading Update
January 15, 2026
PDMR Shareholding/Share Incentive Plan and TVR
November 4, 2025
Block listing Interim Review
October 7, 2025
H1 2025 Results
September 23, 2025
Notice of Results
September 11, 2025
Holding(s) in Company
September 9, 2025
Diaceutics at Canaccord Genuity Growth Conference
August 5, 2025
Diaceutics Announces Key Leadership Appointment
July 29, 2025
Issue of Share Options / PDMR Shareholdings
July 23, 2025
22% Revenue Growth H125 representing 3-yr CAGR 25%
July 22, 2025
Expansion of PMx Commercialization Partnership
July 17, 2025
PDMR Shareholding/SIP and Total Voting Rights
June 30, 2025
Results of AGM
June 18, 2025
PDMR Shareholding /Share Incentive Plan and TVR
June 6, 2025
Notice of AGM and Posting of Annual Report
May 21, 2025
Transaction by Persons Closely Associated to PDMRs
May 15, 2025
FY 2024 Results - Strong Revenue Growth
May 13, 2025
PMx Promotional Partner Contract Enhancement
March 26, 2025
Purchase of Shares and PDMR Shareholding
January 31, 2025
PDMR Shareholding/Share Incentive Plan
January 30, 2025
FY 2024 Trading Update - Strong Revenue Growth
January 28, 2025
Diaceutics Opens US Headquarters
January 14, 2025
New Service Launched & First Contract Signed
January 8, 2025
PDMR Dealings & Total Voting Rights
January 3, 2025
Diaceutics Wins New $5.1m Contract
December 17, 2024
Awarded UK Research Institute Grant Funding of £1m
December 5, 2024
Total Voting Rights
December 3, 2024
Expansion of US Commercial Activities
November 28, 2024
Capital Markets Webinar
November 5, 2024
Board Change Update
October 29, 2024
Issue of Share Options/PDMR Shareholdings
October 25, 2024
Cancellation of Share Premium Account
October 24, 2024
Board Changes
October 1, 2024
H1 2024 Results - Continued Performance & Growth
September 17, 2024
Notice of Results & Presentations
September 9, 2024
Appointment of Nominated Adviser and Broker
September 2, 2024
Diaceutics Launches Enhanced Rare-Disease Offering
August 27, 2024
Enterprise Partnership and Launch of PMx
August 19, 2024